News & Updates
  • Home
  • About Us
  • Contact
  • Home 1
  • News & Updates

    Patented New ISO Name Approved – December 2025: Triflupyroxazin, A New N-phenylimide Herbicide From Liaoning Cynda Chemical Co., Ltd.

    Patented New ISO Name Approved – December 2025: Amfenamacril, A New Aminocyanoacrylate Fungicide From Jiangsu Pesticide Research Institute Co., Ltd.

    Delhi HC refuses FMC’s plea to stop Natco’s Cyantraniliprole commercialization

    ADAMA Launches Combination Herbicide Apresa (flumioxazine + S-metolachlor) in Brazil

    adminJune 24, 202202.5k views

    Summary : Apresa, a premium pre-emergent herbicide for various crops with an exclusive combination of active chemicals (Flumioxazin + S-metolachlor), was introduced…

    Read more

    Merck Scores FDA Approval for Vaxneuvance ( Pneumococcal 15-valent conjugate vaccine) for Ages 6 Weeks through 17 Years

    adminJune 23, 202203.7k views

    Summary : The FDA today approved the pneumococcal 15-valent conjugate vaccine for the prevention of invasive pneumococcal disease in infants and children.…

    Read more

    AbbVie’s Skyrizi (risakizumab-rzaa) Becomes First FDA-Approved IL-23 Inhibitor for Crohn’s Disease

    adminJune 21, 202202.6k views

    Summary : Third approved indication for SKYRIZI (risankizumab-rzaa) is supported by safety and efficacy data from two induction and one maintenance clinical…

    Read more

    New ISO June 2022 Published – Pyriflubenzoxim Herbicide from Chinese Player Jiangsu Agrochem Laboratory

    adminJune 19, 202203k views

    New ISO June 2022 – Pyriflubenzoxim Herbicide from Chinese Player Jiangsu Agrochem Laboratory Pyriflubenzoxim is a new candidate in pyrimidinyl benzoate chemical…

    Read more

    New ISO Published June 2022 – Flufenoximacil Herbicide from Chinese Player Qingdao KingAgroot Chemical Compound Ltd.

    adminJune 19, 202203.3k views

    June 2022 – Qingdao KingAgroot Chemical Compound Co., Ltd. published a new ISO 1750 (provisionally approved) – Flufenoximacil Herbicide. The Flufenoximacil compound…

    Read more

    GSK Unveils New Logo and Branding

    adminJune 18, 202202.9k views

    The British Big Pharma has launched an innovative rebranding, a tech-flavoured logo, and an impactful transformation for the future as GlaxoSmithKline turns…

    Read more

    FDA Approves First Systemic Treatment Olumiant (Baricitinib) for Alopecia Areata

    adminJune 18, 202202.6k views

    Summary : The U.S. Food and Drug Administration approved Olumiant (baricitinib) oral tablets to treat adult patients with severe alopecia areata, a…

    Read more

    Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (Setmelanotide) for Use in Patients with Bardet-Biedl Syndrome

    adminJune 17, 202202.6k views

    Summary : IMCIVREE now available for chronic weight management in adult and pediatric patients 6 years of age and older with monogenic…

    Read more

    Johnson & Johnson, Momenta Pharma File Patent Infringement Lawsuit Against Natco, Mylan in US for Glatiramer Acetate Injection.

    adminJune 16, 202202.6k views

    Summary : Johnson & Johnson and Momenta Pharmaceuticals lawsuit alleges infringement of two old patents associated with 20mg/ml and 40mg/ml Glatiramer Acetate…

    Read more

    Alnylam Scores Another FDA Nod for Amvuttra (Vutrisiran) for the Treatment of Hereditary Transthyretin-Mediated Amyloidosis (hATTR)

    adminJune 15, 202202.2k views

    Summary : Amvuttra (vutrisiran) from Alnylam Pharmaceuticals has been licenced by the US Food and Drug Administration for the treatment of hereditary…

    Read more

    Posts navigation

    1 … 18 … 105
    View Desktop Version

    Powered by PenciDesign

    Back To Top